An M. T. Van Nuffel - Concepedia

Author

An M. T. Van Nuffel

Vrije Universiteit Brussel ORCID

Also Known As

A. M. T. Van Nuffel, A.M.T. Van Nuffel, An M T Van Nuffel, An M. T. Van Nuffel, An M.T. Van Nuffel, An MT Van Nuffel

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Vrije Universiteit Brussel Universitair Ziekenhuis Brussel Anticancer Fund KU Leuven Antwerp University Hospital

About

An M. T. Van Nuffel is an author at Vrije Universiteit Brussel specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	796
2	Immunology	9	9	666
3	Health Sciences	1	1	130
4	Allergy	1	1	152
5	Cell Biology	1	1	15

An M. T. Van Nuffel

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients Sofie Wilgenhof, An M. T. Van Nuffel, Daphné Benteyn, Annals of Oncology Phase Ib StudyTranslational MedicineDendritic Cell ImmunotherapyMelanomaImmunology	2013	195
Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L, CD70 and Constitutively Active TLR4 Encoding mRNA Aude Bonehill, Sandra Tuyaerts, An M. T. Van Nuffel, Molecular Therapy	2008	182
Single-Step Antigen Loading and Activation of Dendritic Cells by mRNA Electroporation for the Purpose of Therapeutic Vaccination in Melanoma Patients Aude Bonehill, An M. T. Van Nuffel, Jurgen Corthals, Clinical Cancer Research	2009	163
Therapeutic Vaccination With an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Advanced Melanoma Sofie Wilgenhof, An M. T. Van Nuffel, Jurgen Corthals, Journal of Immunotherapy ImmunodeficienciesImmunologyImmune RegulationImmunoeditingImmunotherapeutics	2011	152
ReDO_DB: the repurposing drugs in oncology database Pan Pantziarka, Ciska Verbaanderd, Vidula Sukhatme, ecancermedicalscience Possible Cancer TreatmentsChemoprevention StrategyPharmacotherapyTumor BiologyOncology	2018	130
Dendritic Cells Loaded With mRNA Encoding Full-length Tumor Antigens Prime CD4+ and CD8+ T Cells in Melanoma Patients An M. T. Van Nuffel, Daphné Benteyn, Sofie Wilgenhof, Molecular Therapy	2012	92
Characterization of CD8<sup>+</sup>T-Cell Responses in the Peripheral Blood and Skin Injection Sites of Melanoma Patients Treated with mRNA Electroporated Autologous Dendritic Cells (TriMixDC-MEL) Daphné Benteyn, An M. T. Van Nuffel, Sofie Wilgenhof, BioMed Research International	2013	90
Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent An M. T. Van Nuffel ecancermedicalscience Tumor BiologyOncologyAntibioticsGastric InfectionMedicine	2015	82
Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastases Sofie Wilgenhof, Jurgen Corthals, An M. T. Van Nuffel, Cancer Immunology Immunotherapy Surgical OncologyMedicineMelanomaImmunologyLong-term Clinical Outcome	2014	73
Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient An M. T. Van Nuffel, Daphné Benteyn, Sofie Wilgenhof, Cancer Immunology Immunotherapy Durable Tumor ResponseCancer ImmunosurveillanceMedicineMelanomaImmunology	2011	63

Page 1